{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:34:07Z","timestamp":1790112847265,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"High-Tech Research Center Project"},{"DOI":"10.13039\/501100001700","name":"MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.leukres.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T23:31:39Z","timestamp":1342654299000},"page":"1315-1322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells"],"prefix":"10.1016","volume":"36","author":[{"given":"Masanobu","family":"Tsubaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Satou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Imano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Komai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minori","family":"Nishinobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yanae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Yamazoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2012.07.003_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/asheducation-2007.1.317","article-title":"The treatment of relapsed and refractory multiple myeloma","volume":"1","author":"Richardson","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.leukres.2012.07.003_bib0010","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1080\/10428190802064941","article-title":"Treatment of relapsed and refractory myeloma","volume":"49","author":"Reece","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.003_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1349-7006.2003.tb01345.x","article-title":"Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal","volume":"94","author":"Tsuruo","year":"2003","journal-title":"Cancer Sci"},{"issue":"7","key":"10.1016\/j.leukres.2012.07.003_bib0020","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/cr9000226","article-title":"ABC efflux pump-based resistance to chemotherapy drugs","volume":"109","author":"Eckford","year":"2009","journal-title":"Chem Rev"},{"issue":"47","key":"10.1016\/j.leukres.2012.07.003_bib0025","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/sj.onc.1206947","article-title":"Vaults: a ribonucleoprotein particle involved in drug resistance?","volume":"22","author":"Mossink","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.003_bib0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000235820","article-title":"MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma","volume":"122","author":"Buda","year":"2009","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.leukres.2012.07.003_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00280-006-0367-6","article-title":"Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status","volume":"60","author":"Minderman","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.leukres.2012.07.003_bib0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbrc.2007.07.049","article-title":"Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors","volume":"361","author":"Rumpold","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"5303","key":"10.1016\/j.leukres.2012.07.003_bib0045","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.275.5303.1132","article-title":"The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis","volume":"275","author":"Kluck","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.leukres.2012.07.003_bib0050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V88.2.386.bloodjournal882386","article-title":"Molecular thanatopsis: a discourse on the BCL2 family and cell death","volume":"88","author":"Yang","year":"1996","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2012.07.003_bib0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM198701083160204","article-title":"Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer","volume":"316","author":"Yunis","year":"1987","journal-title":"N Engl J Med"},{"issue":"5303","key":"10.1016\/j.leukres.2012.07.003_bib0060","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.275.5303.1129","article-title":"Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked","volume":"275","author":"Yang","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.leukres.2012.07.003_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.leukres.2012.07.003_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.124.1.1","article-title":"Bcl-2 and the regulation of programmed cell death","volume":"124","author":"Reed","year":"1994","journal-title":"J Cell Biol"},{"issue":"13","key":"10.1016\/j.leukres.2012.07.003_bib0075","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.97.13.7124","article-title":"Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells","volume":"97","author":"Wang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"30","key":"10.1016\/j.leukres.2012.07.003_bib0080","doi-asserted-by":"crossref","first-page":"9485","DOI":"10.1021\/bi025605h","article-title":"Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2 Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death","volume":"41","author":"Shangary","year":"2002","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.leukres.2012.07.003_bib0085","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1200\/JCO.1999.17.9.2941","article-title":"Dysregulation of apoptosis in cancer","volume":"17","author":"Reed","year":"1999","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.leukres.2012.07.003_bib0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bjc.1986.83","article-title":"Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells","volume":"53","author":"Twentyman","year":"1986","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.003_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bcp.2009.03.026","article-title":"Influx and efflux transport as determinants of melphalan cytotoxicity: resistance to melphalan in MDR1 overexpressing tumor cell lines","volume":"78","author":"K\u00fchne","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.003_bib0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.1994.12.1.115","article-title":"MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents","volume":"12","author":"Cornelissen","year":"1994","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.leukres.2012.07.003_bib0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/bjc.1992.95","article-title":"Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma","volume":"65","author":"Linsenmeyer","year":"1992","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2012.07.003_bib0110","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrm2952","article-title":"Mitochondria and cell death: outer membrane permeabilization and beyond","volume":"11","author":"Tait","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2012.07.003_bib0115","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1038\/onc.2009.52","article-title":"Mimicking the BH3 domain to kill cancer cells","volume":"27","author":"Chonghaile","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.leukres.2012.07.003_bib0120","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.V90.3.1208","article-title":"Bcl-2 Bcl-XL can differentially block chemotherapy-induced cell death","volume":"90","author":"Simonian","year":"1997","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2012.07.003_bib0125","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/ijc.22055","article-title":"Resistance to apoptosis of HCW-2 cells can be overcome by curcumin- or vincristine-induced mitotic catastrophe","volume":"119","author":"Magalska","year":"2006","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2012.07.003_bib0130","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ijc.23122","article-title":"Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K\/Akt pathway","volume":"122","author":"Cordo Russo","year":"2008","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.leukres.2012.07.003_bib0135","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2009-07-232801","article-title":"IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms","volume":"115","author":"De Bruyne","year":"2010","journal-title":"Blood"},{"issue":"54","key":"10.1016\/j.leukres.2012.07.003_bib0140","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1038\/sj.onc.1208949","article-title":"Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1\/Bim complex","volume":"24","author":"Gomez-Bougie","year":"2005","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.leukres.2012.07.003_bib0145","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.leukres.2009.06.004","article-title":"Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3","volume":"33","author":"Nuutinen","year":"2009","journal-title":"Leuk Res"},{"issue":"14","key":"10.1016\/j.leukres.2012.07.003_bib0150","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1182\/blood-2010-02-268003","article-title":"Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma","volume":"116","author":"Richter-Larrea","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2012.07.003_bib0155","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.bcp.2007.08.004","article-title":"The involvement of AMP-activated protein kinases in the anti-inflammatory effect of nicotine in vivo and in vitro","volume":"74","author":"Cheng","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.leukres.2012.07.003_bib0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3835(01)00834-5","article-title":"Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins)","volume":"180","author":"Notarbartolo","year":"2002","journal-title":"Cancer Lett"},{"issue":"11","key":"10.1016\/j.leukres.2012.07.003_bib0165","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.20656","article-title":"IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes","volume":"81","author":"Nakagawa","year":"2006","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.leukres.2012.07.003_bib0170","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2141.2007.06714.x","article-title":"Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells","volume":"138","author":"Hideshima","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.leukres.2012.07.003_bib0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.2006.06435.x","article-title":"Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells","volume":"136","author":"Hazlehurst","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.leukres.2012.07.003_bib0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2009.07608.x","article-title":"The imbalance between Survivin and Bim mediates tumour growth and correlates with poor survival in patients with multiple myeloma","volume":"145","author":"Romagnoli","year":"2009","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.leukres.2012.07.003_bib0185","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.20656","article-title":"IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes","volume":"81","author":"Nakagawa","year":"2006","journal-title":"Am J Hematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612002901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612002901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:58:01Z","timestamp":1758934681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212612002901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0145212612002901"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2012.07.003","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2012.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}